← All companies

FLNA

Filana Therapeutics, Inc.

FLNA Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.03

+0.02 +1.98%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.86 – $4.98

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Director or officer change; Shareholder vote results Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Amended charter or bylaws; Regulation FD disclosure Mar 10, 2026 8-K Regulation FD disclosure; Other events Feb 19, 2026 8-K Entered a material agreement Dec 23, 2025 8-K/A Director or officer change Dec 22, 2025 8-K Other events Dec 18, 2025 8-K Director or officer change Dec 17, 2025 8-K Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Oct 24, 2025 8-K Director or officer change; Regulation FD disclosure Oct 22, 2025 8-K Regulation FD disclosure Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Regulation FD disclosure; Other events Aug 4, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Director or officer change; Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change; Regulation FD disclosure Apr 21, 2025 8-K Regulation FD disclosure; Other events Mar 25, 2025 8-K Director or officer change Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Entered a material agreement; Regulation FD disclosure Feb 27, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Other events Jan 7, 2025 8-K Other events Nov 25, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure Oct 8, 2024 8-K/A Director or officer change Oct 1, 2024 8-K Regulation FD disclosure; Other events Sep 27, 2024